These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21106545)

  • 1. Immunohistochemical assessment for Cdx2 expression in the Barrett metaplasia-dysplasia-adenocarcinoma sequence.
    Hayes S; Ahmed S; Clark P
    J Clin Pathol; 2011 Feb; 64(2):110-3. PubMed ID: 21106545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of αGlcNAc in Barrett's oesophagus adjacent to Barrett's adenocarcinoma--a possible biomarker to predict the malignant potential of Barrett's oesophagus.
    Iwaya Y; Hasebe O; Koide N; Kitahara K; Suga T; Shinji A; Muraki T; Yokosawa S; Yamada S; Arakura N; Tanaka E; Nakayama J
    Histopathology; 2014 Mar; 64(4):536-46. PubMed ID: 24117499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical assessment of Survivin and Bcl3 expression as potential biomarkers for NF-κB activation in the Barrett metaplasia-dysplasia-adenocarcinoma sequence.
    Puccio I; Khan S; Butt A; Graham D; Sehgal V; Patel D; Novelli M; Lovat LB; Rodriguez-Justo M; Hamoudi RA
    Int J Exp Pathol; 2018 Feb; 99(1):10-14. PubMed ID: 29473241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2, CDX2, and CDC2 immunohistochemical assessment for dysplasia-carcinoma progression in Barrett's esophagus.
    Villanacci V; Rossi E; Zambelli C; Galletti A; Cestari R; Missale G; Casa DD; Bassotti G
    Dig Liver Dis; 2007 Apr; 39(4):305-11. PubMed ID: 17307036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus.
    Phillips RW; Frierson HF; Moskaluk CA
    Am J Surg Pathol; 2003 Nov; 27(11):1442-7. PubMed ID: 14576477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdx2 expression and its promoter methylation during metaplasia-dysplasia-carcinoma sequence in Barrett's esophagus.
    Makita K; Kitazawa R; Semba S; Fujiishi K; Nakagawa M; Haraguchi R; Kitazawa S
    World J Gastroenterol; 2013 Jan; 19(4):536-41. PubMed ID: 23382633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent expression of MUC5AC, MUC6, MUC2, CD10, and CDX-2 in dysplasia and intramucosal adenocarcinomas with intestinal and foveolar morphology: is this evidence of distinct gastric and intestinal pathways to carcinogenesis in Barrett Esophagus?
    Khor TS; Alfaro EE; Ooi EM; Li Y; Srivastava A; Fujita H; Park Y; Kumarasinghe MP; Lauwers GY
    Am J Surg Pathol; 2012 Mar; 36(3):331-42. PubMed ID: 22261707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Foveolar type dysplasia in Barrett esophagus.
    Brown IS; Whiteman DC; Lauwers GY
    Mod Pathol; 2010 Jun; 23(6):834-43. PubMed ID: 20228780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite instability in metaplasia-dysplasia-adenocarcinoma sequence of Barrett esophagus: a retrospective study.
    Markoš P; Brčić I; Brčić L; Jakić-Razumović J; Pulanić R
    Croat Med J; 2018 Jun; 59(3):100-107. PubMed ID: 29972732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased CDX2 and decreased PITX1 homeobox gene expression in Barrett's esophagus and Barrett's-associated adenocarcinoma.
    Lord RV; Brabender J; Wickramasinghe K; DeMeester SR; Holscher A; Schneider PM; Danenberg PV; DeMeester TR
    Surgery; 2005 Nov; 138(5):924-31. PubMed ID: 16291394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch signaling pathway and Cdx2 expression in the development of Barrett's esophagus.
    Tamagawa Y; Ishimura N; Uno G; Yuki T; Kazumori H; Ishihara S; Amano Y; Kinoshita Y
    Lab Invest; 2012 Jun; 92(6):896-909. PubMed ID: 22449796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CDX2 and LI-cadherin expression in esophageal mucosa: use of both markers can facilitate the histologic diagnosis of Barrett's esophagus and carcinoma.
    Weimann A; Zimmermann M; Gross M; Slevogt H; Rieger A; Morawietz L
    Int J Surg Pathol; 2010 Oct; 18(5):330-7. PubMed ID: 20444732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The homeodomain protein CDX2 is an early marker of Barrett's oesophagus.
    Moons LM; Bax DA; Kuipers EJ; Van Dekken H; Haringsma J; Van Vliet AH; Siersema PD; Kusters JG
    J Clin Pathol; 2004 Oct; 57(10):1063-8. PubMed ID: 15452161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDX2 and villin are useful markers of intestinal metaplasia in the diagnosis of Barrett esophagus.
    Shi XY; Bhagwandeen B; Leong AS
    Am J Clin Pathol; 2008 Apr; 129(4):571-7. PubMed ID: 18343784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemistry for CDX2 expression in non-goblet-cell Barrett's oesophagus.
    Behan M; Gledhill A; Hayes S
    Br J Biomed Sci; 2014; 71(2):86-92. PubMed ID: 24974686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma.
    Pavlov K; Honing J; Meijer C; Boersma-van Ek W; Peters FT; van den Berg A; Karrenbeld A; Plukker JT; Kruyt FA; Kleibeuker JH
    Dig Liver Dis; 2015 Jan; 47(1):73-80. PubMed ID: 25445407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact of MUC1 and MUC4 expression in Barrett-associated oesophageal adenocarcinoma.
    Piessen G; Wacrenier A; Briez N; Triboulet JP; Van Seuningen I; Mariette C
    J Clin Pathol; 2009 Dec; 62(12):1144-6. PubMed ID: 19946103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach.
    Ko S; Chu KM; Luk JM; Wong BW; Yuen ST; Leung SY; Wong J
    J Pathol; 2005 Apr; 205(5):615-22. PubMed ID: 15732140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of CDX2 expression in esophageal adenocarcinoma.
    Vaninetti N; Williams L; Geldenhuys L; Porter GA; Guernsey DL; Casson AG
    Mol Carcinog; 2009 Oct; 48(10):965-74. PubMed ID: 19415720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Myc overexpression is strongly associated with metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    Schmidt MK; Meurer L; Volkweis BS; Edelweiss MI; Schirmer CC; Kruel CD; Gurski RR
    Dis Esophagus; 2007; 20(3):212-6. PubMed ID: 17509117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.